Our healthcare law firm works with many providers and healthcare practices to assist them in complying with federal, state, and local laws. Several of our clients have asked if they can administer stem cell treatments as part of their practice. This blog post discusses a bill in the Georgia General Assembly that proposes to regulate stem cell treatments. As of April 29, 2026, the bill has passed both the Georgia House and Senate, has been sent to the Governor, but has not yet become law. If you are planning to administer stem cell treatments as part of your practice or would like to discuss this blog post, you may contact our healthcare law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.
House Bill 1275 (HB 1275) proposes to regulate stem cell treatments that are intended for regenerative treatments, not for human research purposes. The bill states that physicians, physician assistants, or nurse practitioners can perform non-FDA-approved stem cell therapies if the therapies are used for “treatment or procedures that are within the scope of practice of the physician, physician assistant, or nurse practitioner, so long as the patient is advised and signs a consent form.” As such, stem cell therapies would require the patient to obtain informed consent before agreeing to proceed with stem cell therapy.
HB 1275 also lists requirements for human stem cells before they can be included as part of stem cell therapy. Under the bill, human stem cells must be retrieved, manufactured, and stored in an FDA-registered facility. The facility can be in Georgia or anywhere else in the world. The facility can also be certified and accredited by several entities other than the FDA, including the World Marrow Donor Association.
The bill also requires physicians, physician assistants, or nurse practitioners to include specific language laid out in the bill in any advertisement if they intend to perform stem cell therapy. The advertisement language notifies patients that the stem cell therapy is not FDA-approved and encourages patients to consult with their primary care provider before undergoing any stem cell therapy. If a physician, physician assistant, or nurse practitioner violates any provision of this bill, the provider may be subjected to disciplinary action from the Georgia Medical Board or Georgia Nursing Board.
If you are planning to administer stem cell treatments as part of your practice or would like to discuss this blog post, you may contact our healthcare law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.
Little Health Law Blog

